203293
InSolution™ Bisindolylmaleimide I
2-[1-(3-Dimethylaminopropyl)-1H-indol-3-yl]-3-(1H-indol-3-yl)-maleimide, Gö 6850
| Product information | |||
|---|---|---|---|
| Form | Liquid | ||
| Formulation | A 1 mg/ml solution of Bisindolylmaleimide I (Cat. No. 203290) in anhydrous DMSO. | ||
| Primary Target | PKC | ||
| Primary Target Ki | 10 nM | ||
| Secondary target | GSK-3 (IC50 = 360 nM), GSK-3β (IC50 = 170 nM), PKA (Ki = 2 mM) | ||
| Molar mass | 412.5 | ||
| Packaged under inert gas | Yes | ||
| Cell permeable | Yes | ||
| Reversible | Yes | ||
| ATP Competitive | Yes | ||
| Purity | ≥95% by HPLC | ||
| Chemical formula | C25H24N4O2 | ||
| CAS number | 133052-90-1 | ||
| Declaration | Sold under license of U.S. Patent 5,380,746. | ||
| Store and ship information | |||
|---|---|---|---|
| Storage | -20°C | ||
| Ship |
Blue or Dry Ice
Irritant |
||
| Safety information | |||
|---|---|---|---|
| S Phrase |
S: 26 In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. |
||
| R Phrase |
R: 36/38 |
||
